recorder.caSEP 222 min read$TRLV

Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices

Trulieve Cannabis Corp. (TRLV) has been added to the S&P Total Market Index, S&P Completion Index, and related healthcare sub-indices. According to the company, this inclusion is expected to increase visibility, liquidity, and attract new institutional investors. Trulieve is a vertically integrated cannabis company operating in several U.S. states and listed on the NYSE.

Original reporting

recorder.ca

Published Sep 22, 2026, 12:30 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Sep 22, 2026, 1:22 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices — source image — Source · recorder.ca

Decision brief

The 30-second read

$TRLVBullishMed

Why it matters

The inclusion in S&P benchmarks is expected to broaden the investor base and improve liquidity.

Market read

Index inclusion is a catalyst for small‑cap stocks, potentially driving price appreciation and tighter spreads.

What to watch

Regulatory risk and state‑level licensing constraints remain unchanged despite index addition.

Relevance 6/10Novelty 7/10Timing: effective immediately on announcement date

Background

Trulieve is a leading multi‑state medical cannabis operator listed on the NYSE under TRLV.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$TRLVBullishHigh confidence

Context

Trulieve Cannabis Corp. was added to the S&P Total Market Index and S&P Completion Index, a new development that can boost liquidity and attract institutional investors.

Expected impact

moderate upside as index funds add exposure

Evidence & confidence

First‑report of index addition; historically such moves lift small‑cap stocks.

Market effects

Sector

May improve perception of the cannabis sector as it gains representation in broad market indices.

Regional

U.S. cannabis stocks could see modest inflows from index‑tracking funds.

Global

Limited to U.S. investors; negligible global impact.

Counterpoint

What could challenge this read

If index inclusion leads to short‑covering rallies, the stock could be overbought quickly.

Key entities

Company
Trulieve Cannabis Corp.
Medical cannabis operator added to S&P indices.
Index Provider
S&P Dow Jones Indices
Publisher of the Total Market and Completion indices.

Read at source ← All news

SEP 30

$TRLVHigh

Why is Trulieve Cannabis stock sliding today?

Trulieve Cannabis (TRLV) shares fell 6.5% in pre-market trading after announcing a licensing deal with Connected Cannabis, which investors reassessed for costs and risks. CEO Kim Rivers' share sale plan and institutional rebalancing added pressure. Q2 revenue was $271M, down 10% YoY, with a net loss. Broader market conditions offered no support.

investing.com1 min

SEP 29

$MSOSHigh

MSOS, TRLV Slide After Hours As DEA Judge Pauses Cannabis Rescheduling Case

MSOS, an ETF, and TRLV, one of its holdings, fell about 8-9% after hours as a federal judge paused a cannabis rescheduling case. The delay impacts investors' expectations for near-term changes to marijuana's legal status, which could affect the industry.

stocktwits.com2 min

AUG 29

$TRLVMed

Trulieve Cannabis (TRLV) Is Up 6.5% After ESOP-Linked US$55.5 Million Share Issuance - Has The Bull Case Changed?

Trulieve Cannabis (TRLV) issued 10 million shares worth $55.5 million in an ESOP-related offering, causing a 6.5% stock price increase. The company also authorized a $50 million share buyback program. Analysts project varying revenue and earnings forecasts for 2029, with some seeing significant upside and others a more pessimistic outlook. Q2 2026 sales declined year over year, and net loss widened, keeping margin trends and capital deployment in focus.

simplywall.st3 min

AUG 29

$ZIMMedAI 8/10

Dow, S&P 500, Nasdaq Futures Rise On AI, Fed Watch After Holiday Break: Why ZIM, AAPL, TCNNF, DIS Kept Traders On Edge Today

U.S. stock futures rose late Monday, with Nasdaq up 0.01%, S&P 500 up 0.1%, and Dow up 0.05%. Investors focused on AI disruption, Fed rate path, and inflation data. ZIM agreed to a $4.2B acquisition by Hapag-Lloyd at $35 per share. AAPL announced a March 4 event, potentially featuring new products. TCNNF and DIS also drew attention.

stocktwits.com2 min

AUG 10

$TRLVMedAI 8/10

Trulieve Cannabis Q2 Earnings Call Highlights

Trulieve Cannabis reported Q2 revenue of $271 million, including $222 million medical-only revenue. Adjusted EBITDA was $98 million (36% margin). Operating cash flow was $53 million and free cash flow $32 million, with $325 million cash and $289 million debt. The company authorized a $50 million share repurchase program in June. It expects Q3 medical-only revenue comparable to $222 million and raised capex to $95 million.

yahoo.com7 min

AUG 7